02/14/2024 1:26 PM | ARMISTICE CAPITAL, LLC (Filed by) Deciphera Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024 4:32 PM | Deciphera Pharmaceuticals (Subject) Flynn James E (Filed by)
| Form SC 13G/A | |
02/09/2024 3:30 PM | Brightstar Associates LLC (Filed by) Deciphera Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024 3:30 PM | Brightstar Associates LLC (Reporting) Deciphera Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2024 6:52 AM | Deciphera Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/07/2024 6:11 AM | Deciphera Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/06/2024 3:52 PM | Deciphera Pharmaceuticals (Subject) GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by)
| Form SC 13G/A | |
|
02/06/2024 6:10 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/23/2024 8:45 AM | Deciphera Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024 3:15 PM | Deciphera Pharmaceuticals (Issuer) Squarer Ron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 3:15 PM | Deciphera Pharmaceuticals (Issuer) Martin Daniel C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 3:15 PM | Allen Patricia L (Reporting) Deciphera Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 3:15 PM | Deciphera Pharmaceuticals (Issuer) Kelly Thomas Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 3:15 PM | Deciphera Pharmaceuticals (Issuer) Friedman Franklin Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 3:15 PM | Deciphera Pharmaceuticals (Issuer) Pitman Jama (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 3:15 PM | Deciphera Pharmaceuticals (Issuer) Walsh Dennis Leo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 3:15 PM | Deciphera Pharmaceuticals (Issuer) Sherman Matthew L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 6:14 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/01/2023 3:05 PM | Deciphera Pharmaceuticals (Issuer) Martin Daniel C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2023 5:05 PM | Deciphera Pharmaceuticals (Subject) Martin Daniel C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2023 6:06 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2023 6:11 AM | Deciphera Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/05/2023 3:15 PM | Deciphera Pharmaceuticals (Issuer) Dhanak Dashyant (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/09/2023 6:06 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/09/2023 6:09 AM | Deciphera Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/23/2023 3:05 PM | Allen Patricia L (Reporting) Deciphera Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:05 PM | Deciphera Pharmaceuticals (Issuer) Squarer Ron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:05 PM | Deciphera Pharmaceuticals (Issuer) Kelley Susan L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:05 PM | Deciphera Pharmaceuticals (Issuer) Walsh Dennis Leo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:05 PM | Deciphera Pharmaceuticals (Issuer) Friedman Franklin Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:05 PM | Bristol James Arthur (Reporting) Deciphera Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:05 PM | Benz Edward J. JR (Reporting) Deciphera Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:05 PM | Deciphera Pharmaceuticals (Issuer) Martin John Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2023 3:06 PM | Deciphera Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2023 3:05 PM | Deciphera Pharmaceuticals (Issuer) Flynn Daniel Lee (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 3:05 PM | Deciphera Pharmaceuticals (Issuer) Martin Daniel C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 3:05 PM | Deciphera Pharmaceuticals (Issuer) Kelly Thomas Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 3:05 PM | Deciphera Pharmaceuticals (Issuer) Sherman Matthew L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 3:05 PM | Deciphera Pharmaceuticals (Issuer) Pitman Jama (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 7:45 AM | Deciphera Pharmaceuticals (Filer)
| Form S-3ASR | |
05/03/2023 6:07 AM | Deciphera Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
This consistently signaled gains of 453%... 610%... and even 1036%... (Ad) It doesn’t happen often, but occasionally, something completely unique comes across my radar.
In this case, I’m talking about legal “Insider Trading”.
Traders who have consistently signaled 453% … 610% .. and even 1036%... gains.
And until now they have been doing it completely under the radar.
In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade. Register for the imminent briefing here. |
05/03/2023 6:10 AM | Deciphera Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/26/2023 7:05 AM | Deciphera Pharmaceuticals (Filer)
| Form DEF 14A | |
04/26/2023 7:06 AM | Deciphera Pharmaceuticals (Filer)
| Form DEFA14A | |
04/26/2023 7:14 AM | Deciphera Pharmaceuticals (Filer)
| Form ARS | |